Clinical trials
Phase 2 Urinary Bladder Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Europe B.V. | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Nova Scotia Health Authority | 1 |
| The Methodist Hospital Research Institute | 1 |
| The Netherlands Cancer Institute | 1 |
| Urigen | 1 |
| UroGen Pharma Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Diseases | 9 |
| Urologic Diseases | 5 |
| Cystitis, Interstitial | 4 |
| Urinary Bladder Neoplasms | 4 |
| Urologic Neoplasms | 3 |
| Neoplasms | 2 |
| Carcinoma in Situ | 1 |
| Cystitis | 1 |
| Female Urogenital Diseases | 1 |
| Female Urogenital Diseases and Pregnancy Complications | 1 |
Trials
Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.